EGFR and cancer: Neuropilin-1 (NRP1, BDCA-4) induces a c-Jun N-terminal kinase (JNK)-dependent signaling cascade that leads to the upregulation of EGFR or IGF1R, thereby promoting cancer cell growth (Rizzolio et al., 2020).